Effects of Dl-3n-Butylphthalide Against Diffuse Brain Injury

Dl-3n-butylphthalide can effectively treat cerebral ischemia. However, the mechanisms underlying the effects of dl-3n-butylphthalide on microcirculation disorders following diffuse brain injury remain unclear.

Dl-3n-butylphthalide can effectively treat cerebral ischemia. However, the mechanisms underlying the effects of dl-3n-butylphthalide on microcirculation disorders following diffuse brain injury remain unclear.

According to a study by Prof. Jianmin Li and team from Hebei United University of China, models of diffuse brain injury were established in Sprague-Dawley rats with the vertical impact method, and dl-3n-butylphthalide at 80 and 160 mg/kg was given via intraperitoneal injection immediately after diffuse brain injury.

Research Explores Use of Salvianolate for Treatment of Cerebral Ischemia-Reperfusion Injuries
Previous research has shown that salvianolic acid B is a phenolic acid compound composed of three Danshensu units and one molecule of caffeic acid.

After administration of dl-3n-butylphthalide, reduced cerebral ultrastructure damage, increased vascular density and cerebral blood flow, and improved motor and sensory functions were observed. These findings, published in the Neural Regeneration Research (Vol. 8, No. 28, 2013), demonstrate that dl-3n-butylphthalide may have protective effects against diffuse brain injury by ameliorating microcirculation disorder and reducing blood-brain barrier damage and cerebral edema.

Source-Eurekalert

Monitoring and Treatment of Children With Traumatic Brain Injury Varies With Hospitals
A new study suggests that the management of children with traumatic brain injury varies with hospitals.

Amyloid Deposition in Patients With Traumatic Brain Injury Examined in Study
A study found that patients with traumatic brain injury (TBI) had increased deposits of Amyloid plaques in some areas of their brains.

Stem Cells Linked to Cognitive Gain After Brain Injury: Study
In the critical time window, a stem cell therapy previously shown to reduce inflammation after traumatic brain injury also promotes lasting cognitive improvement.